T his article reports the use of Corning Epic systemd a label-free and noninvasive optical system that is centered on resonant waveguide grating biosensorsdto profile endogenous G protein-coupled receptors (GPCRs) in living cells under physiologically relevant conditions. The endogenous GPCRs examined were bradykinin B 2 receptor in A431 cells and protease-activated receptor subtype 1 (PAR 1 ) in Chinese hamster ovary (CHO) cells. The activation of either receptor led to G q -mediated signaling in the respective cells, as confirmed by Fluo-3 assays. Stimulation of CHO cells with thrombin, a PAR 1 natural agonist, resulted in an optical response relating to dynamic mass redistribution that is similar to that induced by bradykinin in A431 cells. Based on the kinetics of agonist-mediated optical signatures, two time points, one before and another 5 min after the stimulation, were chosen to develop high-throughput (HT) screening assays. Results showed that such endpoint measurements enable not only HT screening of compounds using endogenous GPCRs, but also determining the efficacies of agonists. Those results suggested that the Corning Epic label-free system is an easily scaleable biosensor, amenable as an HTS platform for GPCR drug discovery and deorphanization. ( JALA 2006; 11:181-7) 
INTRODUCTION
G protein-coupled receptors (GPCRs) are a superfamily of membrane proteins, which are involved in almost all aspects of human physiology ranging from neurotransmission to cardiovascular function. 1, 2 The modulation of GPCRs is a major mechanism for modern therapeutic intervention, partly because they are addressable by small molecular medicine, and partly because they are widely implicated in the development and progression of major diseases such as cardiovascular, respiratory, gastrointestinal, neurological, psychiatric, and metabolic disorders. 3, 4 GPCRs represent the single largest family of druggable targets in the human genome and have proven to be the most productive area for small molecule drug discovery. 5e8 Screening drugs against this class of protein targets is still a major effort in pharmaceutical and biotech industries, driven by the fact that the current GPCR-based drugs only target w25% of the approximately 200 known GPCRs 5 ; and there are increasing numbers of GPCR targets due to the completion of the human genome project. 9 The primary function of GPCRs is to transduce extracellular information into intracellular signals through activation of heterotrimeric G proteins and dynamic interactions with intracellular proteins.
Keywords: resonant waveguide grating biosensor, G protein-coupled receptors, high-throughput screening, bradykinin, thrombin Ligand binding to a GPCR mediates a series of spatial and temporal events that govern the cell responses, leading to an ordered, regulated, and dynamic redistribution of cellular contents. 10e13 Monitoring such dynamic redistribution should provide an insight into GPCR signaling and a powerful means for GPCR screens. 14e16 Following the studies on signaling mediated through epidermal growth factor receptor, 17 as well as endogenous bradykinin B 2 receptor 18 in human epidermoid carcinoma A431 cells, we have developed a noninvasive cell-based assay technology based on the recording of dynamic mass redistribution (DMR) using resonant waveguide grating (RWG) biosensors. The DMR signal measured correlates with stimulation-induced dynamic redistribution of cellular contents within the bottom portion of adherent cells. This technology has been applied to study the kinetics, signaling pathways, and network interactions of B 2 receptor in A431 cells. 18 Because the DMR responses induced by B 2 agonists proceed for a prolonged period of time (tens of minutes), the suitability of this technology for highthroughput (HT) screening still remains to be demonstrated. In this article, we examine the feasibility of Corning Epic label-free system to profile and screen compounds against endogenous GPCRs in living cells in an HT fashion, and discuss how to adapt this technology for HT screening.
MATERIALS AND METHODS

Reagents
Thrombin was purchased from Sigma Chemical Co. (St. Louis, MO). Fluo-3 was obtained from Molecular Probes (Eugene, OR). Bradykinin, HOE140, desArg 10 -HOE140, and YFLLRNP were obtained from Bachem (King of Prussia, PA). Corning Epic 384-well biosensor microplates were obtained from Corning Inc (Corning, NY) and cleaned by exposure to high-intensity UV light (UVO-cleaner, Jelight Company Inc., Laguna Hills, CA) for 6 min before use. In the sensor microplate, each well contains an RWG sensor consisting of a thin film of dielectric material on the grating-presenting substrate.
Cell Culture
Both human epidermoid carcinoma A431 cells and Chinese hamster ovary (CHO-K1) cells were obtained from American Type Cell Culture. For culturing, A431 cells were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 4.5 g/L glucose, 2 mM glutamine, and antibiotics. Cells, w1e2 Â 10 4 , at passages 3e5 suspended in 50 ml of the growth medium were placed in each well. After cell seeding, the cells were cultured at 37 C under air/5% CO 2 until w95% confluency was reached (w2e3 days). For culturing CHO cells were grown in Kaighn's modification of Ham's F12 medium (F-12K) supplemented with 10% FBS, 2 mM L-glutamine, 3 mg/mL sodium bicarbonate, and antibiotics. Cells, w8e10 Â 10 3 , suspended in 50 ml of the F-12K medium containing 10% FBS were placed in each well, and were cultured at 37 C under air/5% CO 2 until w95% confluency was reached (w1e2 days).
Fluo-3 Ca 2þ Mobilization Assay
CHO cells at passages 3e5 were grown in Costar 96-well clear cell culture microplates (Corning Inc, Corning, NY) until w95% confluency, washed twice with 1Â HBSS (1Â regular Hank's balanced salt solution, 20 mM HEPES buffer, pH 7.0) in the presence of 2.5 mM probenicid, and labeled in the same buffer containing 4 mM Fluo-3 for 1 h at room temperature. The cells were then washed twice with the HBSS, and maintained with 100 ml HBSS containing 2.5 mM probenicid. The assay was initiated by transferring 100 ml thrombin solution to the cell plate and calcium signal recorded over 6 min with a 6 s interval using HTS7000 Bio-Assay Reader (PerkinElmer Life Science, Boston, MA). The assays were carried out at room temperature to allow direct comparison with optical sensing data.
Corning Epic Label-Free Optical System and DMR Assays
Instead of the angular interrogation system previously used, 17e19 the Epic label-free, wavelength interrogation system with transverse magnetic or p-polarized TM 0 mode was used in this study. For DMR assays, the cells in each well were maintained in the DMEM medium of 40 m and pretreated with a compound solution of 10 ml or 1Â HBSS until a steady phase (i.e., no obvious mass redistribution) was reached (generally within 1 h), before GPCR agonist solution of 10 ml was introduced. All studies were carried out at room temperature with the lid of the microplate on except for a short period of time (wseconds) when the solution was introduced, to minimize the effect of temperature fluctuation and evaporative cooling.
RESULTS AND DISCUSSIONS
Corning Epic System for HTS
The Epic System is centered on RWG biosensors, which are integrated in standard SBS microtiter plates (primarily 384-well microplates). The surfaces of sensors in microplates are modified readily to enable direct coupling of receptors for affinity-based biochemical assays, or appropriate cell attachment and growth for cell-based assays. The cell culturing and handling is not automated, because of the lack of such capability in-house.
As shown in Figure 1a , this system is a stand-alone system and consists of a temperature-control unit, an optical detection unit, and an onboard liquid-handling unit with robotics. The temperature-control unit is built in to minimize temperature fluctuation if any. Inside this unit, there are two sideby-side stacks for holding both the sensor microplates and compound source plates. Once stable temperature is reached, a sensor microplate is transferred by the robotics into the plate holder right above the detection system, whereas a source plate is moved to an appropriate compartment so that it is readily addressable by the onboard liquid-handling unit.
The detection unit is centered on integrated fiber optics to measure the wavelength shift of the resonant lights due to the ligand-induced DMR in living cells. As illustrated in Figure 1b , a broadband white light source, generated through a fiber optic and a collimating lens at nominally normal incidence through the bottom of the microplate, is used to illuminate a small region of the grating surface. A detection fiber for recording the reflected light is bundled with the illumination fiber. A series of illumination/detection heads is arranged in a linear fashion, so that reflection spectra are collected from a subset of wells within the same column of a 384-well microplate at once. The whole plate is scanned by the illumination/detection heads so that each sensor can be addressed multiple times, and each column is addressed in sequence. The scanning could be continuous or discontinuous depending on the assay formats. The wavelengths of the reflected lights are collected and used for analysis.
For kinetic assays, a baseline response is recorded first for a given period of time. Afterward, compound solutions are transferred into the sensor plate using the onboard liquidhandling system, and the cell responses are then recorded for another period of time. The lid of the sensor microplates is on most of the time throughout the assay, except for a short period of time (w2 min) when the compounds are introduced. The plate lid is handled automatically by the robotics. Such kinetic measurement provides useful information for GPCR signaling and its network interactions. 18 For endpoint assays, a baseline reading is obtained by scanning the sensor plates several times (!1 min). Afterward, the compounds are introduced into the sensor plate through either the onboard system or an offline automated liquid-handling system. A final reading is carried out at an appropriate time after compound addition. The difference in wavelength between the two endpoints is used to examine the effect of compounds on living cells. Alternatively, the cells in each well are pretreated individually with a compound for about 1 h and then stimulated with an agonist for a specific GPCR. Two endpoints, right before and after the agonist stimulation, are measured. The difference in wavelength is used to screen modulators (e.g., GPCR antagonist or pathway modulators) against the agonist-targeted receptor and its signaling cascades. The time to assay a 384-well microplate can be completed within 3e5 min. Because the final commercial system will not have an onboard liquidhandling system, we are particularly interested in whether an offline automated liquid-handling step can be integrated into the assays. If feasible, potential customers can implement their in-house liquid-handling system into HTS applications using the Epic System.
Bradykinin-Induced DMR Signals in A431 Cells
The vasoactive nonapeptide bradykinin has been implicated in the regulation of a wide variety of physiological and pathophysiological responses, including vascular permeability, inflammation, pain, and neurotransmitter release. 20 Two bradykinin receptors, B 1 and B 2 , have been identified so far, and B 2 receptor is believed to account for most of the physiological and pathophysiological actions of bradykinin. 21 A431 is known to endogenously express B 2 , but not B 1 receptor. 22 B 2 receptor is either mitogenic or antimitogenic, depending on the experimental conditions. 23 Previously, we 18 and others 22 had found that B 2 signaling in A431 is dependent on the cellular states and the doses of bradykinin. In proliferating states, low doses (!100 nM) of bradykinin trigger G s -mediated signaling, whereas high doses (O100 nM) of bradykinin favor G q -signaling. On the other hand, bradykinin between 0.5 and about 100 nM mediated both G s -and G q -pathways in quiescent A431 cells obtained with 0.1% FBS for about 20 h. 18 Here, we were particularly interested in the optical responses of fully quiescent A431 cells, obtained with the DMEM medium in the absence of any FBS or other growth factors for 20 AE 2 h. Stimulation of such quiescent cells with bradykinin at doses examined led to cellular responses that are dominated by G q -mediated signaling (data not shown). Figure 2a showed classical G q -mediated signaling through a GPCR. As expected, stimulation of the fully quiescent cells with bradykinin led to a typical G q -type optical signature ( Fig. 2a) , which consists of a phase of rapid increase (P-DMR), and a subsequent phase of decrease (N-DMR) (as indicated in Fig. 2c ). The amplitudes of the P-DMR event were saturable to bradykinin at concentrations up to w64 nM, resulting in an EC 50 of 9.2 AE 1.7 nM (n ¼ 5). High doses of bradykinin (O64 nM) further increased the amplitude of both P-DMR and N-DMR events (Fig. 2c ). The pretreatment of cells with a B 2 -specific antagonist HOE 140, but not a B 1 -specific antagonist desArg 10 -HOE140 (both at 1 mM), 24 completely blocked the DMR response induced by 16 nM bradykinin (data not shown), suggesting that the bradykinin-induced responses are specific to the activation of B 2 receptor. These observations are consistent with our previous results obtained using a static angular interrogation system as well as conventional Fluo-3 assays. 18 
Thrombin-Induced DMR Signals in CHO Cells
Thrombin is a serine protease that can site-specifically cleave protease-activated receptor subtype 1 (PAR 1 ) within its extracellular N-terminal exodomain. The cleavage unmasks a new N-terminus, which, in turn, acts as a tethered ligand sequence. The tethered ligand domain binds intramolecularly to and activates the receptor, thus initiating the signaling. 25 PAR 1 is known to be endogenously expressed in CHO cells. 26 Figure 2 . The G q -signaling pathway and its optical signature. (a) Typical G q -mediated signaling through G q -coupled receptors (e.g., B 2 and PAR 1 ) starts with agonist binding, followed by activation of the receptor, its coupled G protein, and its downstream target phospholipase C (PLC) to hydrolyze the membrane lipid phosphatidylinositol bisphosphate (PIP 2 ), producing inositol triphosphate (IP 3 ) and diacylglycerol (DAG). Water-soluble IP 3 diffuses through the cytoplasm to the ER, where it binds to and opens a calcium channel, releasing calcium stores from inside the ER into the cytoplasm. Calcium alters many cellular processes, in part by binding to regulatory proteins such as calmodulin. The interaction of both DAG and calcium with PKC activates its kinase activity, which, in turn, phosphorylates many different protein targets. resulted in an elevation of intracellular Ca 2þ level, as being measured with Fluo-3 assays (Fig. 3a) . The EC 50 was found to be 12.3 AE 2.0 unit/mL (n ¼ 3). This result suggested that thrombin mediates G q signaling in CHO cells. As expected, thrombin triggered a DMR signal in a dosedependent manner in CHO cells (Fig. 3b) . The overall dynamics of the thrombin-induced DMR signals in CHO cells is similar to that of the bradykinin-induced responses in A431 cells, suggesting that the G q -type optical signature initially observed in A431 cells is universal, at least in both cell lines. The nonlinear regression analysis suggested that the optical responses are saturable to thrombin; its saturation curves fit well with one-site binding model (Fig. 3c) . The EC 50 value obtained was found to be 17.5 AE 2.2 unit/mL, consistent with that obtained with Fluo-3 assays. Furthermore, the pretreatment of CHO cells with 243 mM YFLLRNP, a low-affinity PAR 1 -specific partial agonist, 27 almost completely blocked the DMR responses induced by 40 unit/mL thrombin (data not shown), suggesting that the thrombininduced responses are specific to the activation of PAR 1 .
Stimulation of CHO cells with thrombin
Endpoint Measurements Enable HTS
Because the optical responses induced by both GPCR agonists progress for quite a long time (wtens of minutes), kinetic measurements appear not amenable for HTS applications. Next, we examined the feasibility of endpoint measurements for HTS applications. Based on the overall dynamics and characteristic kinetics of both P-DMR and N-DMR events induced by either of GPCR agonists, as well as the saturability of the P-DMR amplitude to the agonist concentration, we chose two time pointsdone before and another 5 min after the addition of the agonist solution. The difference in wavelength between the two endpoints was used as a readout for the agonist-induced responses. An offlineautomated liquid-handling step was used to introduce the compound solutions.
For quiescent A431 cells, half of the wells in a 384-well microplate were treated with 100 nM bradykinin, whereas another half of the wells were treated with the HBSS buffer only. The differences in wavelength between the two endpoints were plotted as a function of the well (Fig. 4) . Results showed that excluding a well containing a bad sensor, the average wavelength shift induced by bradykinin was found to be 785 AE 46 pm (n ¼ 192), whereas the average wavelength shift induced by the HBSS was around 5 AE 3 pm (n ¼ 191).
Similarly, for CHO cells, except for the two columns of a 384-well microplate that were treated with thrombin at different doses, half of the rest of the wells were treated with 40 unit/mL thrombin and another half with the HBSS. As shown in Figure 5 , the average wavelength shift induced by thrombin was found to be 269 AE 19 pm (n ¼ 176). On the other hand, the average wavelength shift induced by the buffer was found to be 17 AE 7 pm (n ¼ 175), after one bad well, as indicated in Figure 5 , was excluded from the data analysis. These results suggested that the endpoint measurements could be used to quantify the DMR responses of the cells induced by either agonist, with great reproducibility and accuracy. Based on these measurements, the Z-factor 28 was found to be around 0.80 and 0.70 for bradykinin in A431 and thrombin in CHO cells, respectively.
Interestingly, the endpoint measurements also enable the determination of thrombin efficacy. Again, the difference in wavelength between two time pointsdone before and another 5 min after the addition of the agonist solutiondis used to quantify the cell response induced by thrombin at different doses. As shown in Figure 6 , thrombin dose dependently increased the wavelength shift until it reaches a steady elevated value, leading to a typical saturation curve with an EC 50 of 12.5 AE 5.1 unit/mL. The EC 50 values obtained were consistent with those obtained using the kinetic measurement ( Fig. 3c ), as well as Fluo-3 assays (Fig. 3a) .
These data also suggested that the offline liquid-handling step can be applied for such endpoint measurements, opening the door for customers to combine their own liquid-handling systems with the Epic System for HTS applications.
CONCLUSION REMARKS
We report here that the Corning Epic label-free screening system allows both kinetic and endpoint measurements of the activation of endogenous GPCRs. Two endogenous GPCRs, bradykinin B 2 receptor in A431 cells and PAR 1 in CHO-K1 cells, were used as examples. The stimulation of A431 cells with bradykinin or CHO cells with thrombin led to similar optical responses relating to DMR. The DMR signals were saturable to either agonist, and were able to be completely blocked by their respective antagonists, suggesting that the optical responses observed were receptor specific. The endpoint measurement not only allows highly reproducible measurement of agonist-induced cell responses, but also enables the determination of agonist efficacies. The offline liquid handling and 5-min endpoint measurement per microplate of 384 wells suggested that the Corning Epic label-free optical system is suitable for HTS applications, particularly for screening GPCR modulators against endogenous receptors under physiologically relevant conditions. Because the DMR signal mediated through a particular target is an integrated response, 17, 18, 29 this noninvasive and label-free technology allows mapping the signaling pathways and network interactions of GPCRs and is thus well suited for deorphanization. 30, 31 protein-coupled receptor. Science 2000, 289, 739e745. Figure 5 . The thrombin-induced wavelength shift in reflected light of each sensor having CHO-K1 cells in comparison with the vehicle (i.e., HBSS)-induced wavelength shift (negative control). The broken gray circle indicates a bad response, probably due to variability in liquid handling. 
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